ZoomInfo Technologies Inc.·4

May 18, 4:26 PM ET

Evans Ashley 4

Research Summary

AI-generated summary

Updated

ZoomInfo Director Ashley Evans Exercises Derivative, Receives RSUs

What Happened
Ashley Evans, a director of ZoomInfo Technologies (GTM), had derivative awards converted/exercised and received a restricted stock unit (RSU) award on May 14, 2026. The Form 4 shows: a conversion/exercise of 19,551 derivative shares that were also reported as a $0 disposition (consistent with a net/cashless settlement), and an acquisition/grant of 51,283 RSUs reported at $0 value on the form. These transactions appear to be compensation-related (exercise/settlement and RSU award) rather than an open-market buy or sale.

Key Details

  • Transaction date: May 14, 2026; Form 4 filed May 18, 2026 (filed on the SEC second business day after the transaction — timely).
  • Derivative exercise/conversion: 19,551 shares (code M); corresponding disposition of 19,551 shares at $0.00 (derivative).
  • Award/grant: 51,283 restricted stock units (code A) reported at $0.00.
  • Shares owned after transaction: not specified in the information provided on this Form 4.
  • Footnotes:
    • F1: Each RSU represents a contingent right to one common share; settlement may be in common stock, cash, or a combination at the issuer’s discretion.
    • F2: Some RSUs vested on May 14, 2026 (the issuer’s annual meeting).
    • F3: Some RSUs will vest on the earlier of May 14, 2027 or the next annual meeting.
  • No indication of a 10b5-1 plan or other special trading plan disclosed on this filing.

Context

  • The 19,551-share derivative activity was reported with a $0 disposition, which commonly indicates a cashless or net settlement used to cover exercise costs and/or tax withholding (i.e., shares were converted and immediately surrendered rather than sold in an open market).
  • The 51,283 RSUs are a grant/compensation award; RSU grants are standard executive/director compensation and do not necessarily signal a buy decision by the insider.
  • For retail investors: grants and exercises tied to compensation schedules are routine and differ from open-market purchases, which are more directly interpreted as an insider’s personal investment signal.